|
|
|
| OTC Healthcare - United Arab Emirates |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s OTC Healthcare Products in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| OTC Healthcare in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| According to official data from the European Commission (based on research of the pharmaceuticals and OTC healthcare markets), the Slovak OTC healthcare market is traditional rather than innovative. ... |
| Clinical Trials: World Market 2009-2024 |
|
| Table of Contents Published: 2009/07 Published by: Visiongain |
| The market for clinical trials has been expanding rapidly in recent years, with impressive revenue growth and important trends. One regional market expanded by 65% in 2008. From the perspectives of various pharma stakeholders, the expanding clinical resea ... |
| Wound Treatments in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Wound Treatments in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Eye Care in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Eye Care in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| NRT Smoking Cessation Aids in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s NRT Smoking Cessation Aids in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Medicated Skin Care in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Medicated Skin Care in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Digestive Remedies in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Digestive Remedies in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Analgesics in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Analgesics in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Inflammatory Bowel Disease Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| The inflammatory bowel disease market is set to grow from $2.9 billion in 2008 to $4.5 billion in 2018 across the seven major markets. While Datamonitor' s updated forecast will parallel its previous forecast up to 2012, several new product launches, regi ... |
| Attention-Deficit Hyperactivity Disorder Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Driven primarily by continued uptake of Shire' s market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. ... |
| Bayer Schering Pharma AG: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Bayer Schering in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Eli Lilly & Co.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Eli Lilly in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Novartis AG: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Novartis in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fo ... |
| Osteoporosis Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Osteoporosis continues to be an attractive therapy area for large pharmaceutical companies due to its high prevalence rate and unmet need. Globally, sales for osteoporosis drugs grew 7.0% year-on-year from 2004 to $9.6 billion in 2008 driven by strong per ... |
| Antihormonal Therapies Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the ... |
| Amgen Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Amgen in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal ... |
| Johnson & Johnson: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for J&J in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales fore ... |
| Pfizer Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Pfizer in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Psoriasis Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This forecast model shows sales of key products used for the treatment of psoriasis, across the seven major markets. Forecast data to 2018 is psoriasis-specific and can be seen in both value and volume units. ... |
| Obesity Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| The obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, re ... |
| Russia Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| Russia's overall macroeconomic situation has stabilised markedly since the end of Q109 ? most notably
as the ruble's managed devaluation earlier in the year did not turn into a rout for the currency, or consume
all of the country's stability fund. Still ... |
| China Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| For the Q309 update of BMI's China Pharmaceuticals & Healthcare report, we have maintained our topline
forecast for medicine expenditure in the world's most populous country, as no new sales figures have
emerged and the country's macroeconomic projectio ... |
| Competitor Analysis: HDAC Inhibitors |
|
| Table of Contents Published: 2009/07 Published by: La Merie |
| The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. ... |
| Medical Affairs Resources, Structures and Trends |
|
| Table of Contents Published: 2009/07 Published by: Best Practices, LLC |
| This Best Practices, LLC study explores how U.S. and global biopharmaceutical companies are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top ... |
| The SADC Healthcare Regulatory Environment |
|
| Table of Contents Published: 2009/07 Published by: Frost & Sullivan |
| This research service identifies and discusses the regulatory framework (including that of medical waste management and medical insurance) of the Southern African Development Communities (SADC) countries. ... |
|
|
|
View Cart
Top